{
    "summary": "The \"Rolling Active Pharmaceutical Ingredient and Drug Reserve Act\" (RAPID Reserve Act) aims to improve supply chain resilience for critical drugs and their active pharmaceutical ingredients (APIs). The bill authorizes the Secretary of Health and Human Services to award contracts to eligible entities to maintain reserves of critical drugs and APIs. These reserves must be regularly replenished and could be tapped during shortages or public health emergencies. The Secretary will also provide guidance and report to Congress on the program's effectiveness, with $500M authorized for fiscal year 2026.",
    "tags": [
        "Healthcare",
        "National security",
        "Emergency response",
        "COVID-19 response",
        "Healthcare access",
        "Opioid crisis",
        "Public safety",
        "Economic stimulus",
        "Job creation",
        "Food security"
    ],
    "category": "Healthcare & Public Health"
}